Centiva Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Centiva Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5M	Buy	90,000 +40,000	+80%	+$4.99M	0.08%	162
2025 Q4	$6.1M	Hold	50,000	–	–	0.05%	233
2025 Q3	$5.01M	Buy	+50,000	New	+$4.5M	0.05%	227
2025 Q1	–	Sell	-18,300	Closed	-$1.65M	–	2209
2024 Q4	$1.65M	Buy	18,300 +3,900	+27%	+$378K	0.03%	403
2024 Q3	$1.42M	Sell	14,400 -4,900	-25%	-$481K	0.03%	638
2024 Q2	$1.79M	Buy	19,300 +16,100	+503%	+$1.44M	0.03%	477
2024 Q1	$304K	Sell	3,200 -16,600	-84%	-$1.54M	0.01%	1240
2023 Q4	$1.77M	Buy	19,800 +7,300	+58%	+$542K	0.04%	393
2023 Q3	$913K	Sell	12,500 -25,000	-67%	-$2M	0.02%	684
2023 Q2	$3.12M	Buy	37,500 +27,500	+275%	+$2.3M	0.07%	274
2023 Q1	$762K	Buy	+10,000	New	+$830K	0.02%	690
2022 Q3	–	Sell	-25,000	Closed	-$1.86M	–	1840
2022 Q2	$1.86M	Buy	+25,000	New	+$1.88M	0.04%	378
2021 Q1	–	Sell	-4,700	Closed	-$662K	–	1451
2020 Q4	$662K	Hold	4,700	–	–	0.03%	375
2020 Q3	$524K	Hold	4,700	–	–	0.03%	321
2020 Q2	$526K	Sell	4,700 -5,100	-52%	-$502K	0.03%	277
2020 Q1	$759K	Hold	9,800	–	–	0.03%	260
2019 Q4	$933K	Buy	+9,800	New	+$848K	0.05%	297

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centiva Capital's XBI Position: Q3 2024 in Review

Centiva Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 4,659 shares — an estimated $458K sold.

Centiva Capital first reported a position in XBI in Q1 2019 and held it in 7 quarters. The position peaked at $4.81M in Q4 2023. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Centiva Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Centiva Capital sold 4,659 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $458K.
Centiva Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 7 quarters.
Centiva Capital's State Street SPDR S&P Biotech ETF position peaked at $4.81M in Q4 2023.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.